Dynport Vaccine Company LLC
Frederick, MD DVC Segment Part of General Dynamics Information Technology, Inc.
- UEI
- LXNEGTYDR755
- CAGE
- 1GFE1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 541330 Engineering Services
- 541511 Custom Computer Programming Services
- 541512 Computer Systems Design Services
- 541519 Other Computer Related Services
- 541611 Administrative Management and General Management Consulting Services
- 541613 Marketing Consulting Services
- 541614 Process, Physical Distribution, and Logistics Consulting Services
- Corporate family
-
-
General Dynamics Information Technology, Inc.
Parent
SMNWM6HN79X5
- Dynport Vaccine Company LLC LXNEGTYDR755
-
General Dynamics Information Technology, Inc.
Parent
SMNWM6HN79X5
- SAM.gov registration date
- Physical address
- 12 W Church St #234, Frederick, MD 21701, USA
- Website
- dxc.com
- Founded
- 2017
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Information Technology
- Software & Services
- IT Services
- Data Processing & Outsourced Services
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Diagnostic pre-clinical services program -IDIQ - dynport | National Institute of Allergy and Infectious Diseases | $3,500 | |
| Diagnostic pre-clinical services program -IDIQ - dynport | National Institute of Allergy and Infectious Diseases | $3,500 | |
| Diagnostic pre-clinical services program -IDIQ - dynport | National Institute of Allergy and Infectious Diseases | $3,500 | |
| Epctu | National Institute of Allergy and Infectious Diseases | $2,265,501 | |
| Evaluation of cell lines producing a monoclonal antibody, and production and characterization of a cgmp master cell bank | National Institute of Allergy and Infectious Diseases | $1,213,178 |
About Dynport Vaccine Company LLC
Dynport Vaccine Company LLC DVC Segment Division is a subsidiary of General Dynamics Corp. that provides a range of research, development, manufacturing, and testing services to support biopharmaceutical products targeting infectious diseases.
Through past federal contracts, Dynport has provided preclinical development, clinical trials, diagnostic testing, vaccine stability evaluations, and cGMP production services in support of therapeutics and vaccines for emerging infectious diseases. Major customers include NIH, HHS, and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. Prime contract awards have funded process development, assay validation, pilot manufacturing, Phase I trials, and stability testing of vaccine candidates over 1-5 year periods. Subcontracts have supported clinical trials and CGMP cell bank production. Most awards utilize firm fixed price or cost plus fixed fee structures without set asides. Places of performance are centered at Dynport's Maryland-based locations.
Dynport holds several infectious disease-focused IDVs as a prime contractor, most notably the $30 million Preclinical Services for Biopharmaceutical Product Development contract from NIH-NIAID. This single-award IDIQ covers process development, assay validation, CGMP production, and regulatory documentation to support candidate vaccines and therapies from early inception through preclinical advancement. Dynport also holds the $36 million Diagnostic Pre-Clinical Services Program contract, which funds development processes needed to bring candidate infectious disease diagnostics to market. Additionally, Dynport is one of multiple awardees under the $346 million Early Phase Clinical Trial Units IDIQ, which has funded Phase I trial services under cost plus fixed fee delivery orders to date.
Contract vehicles
Quick answers
What is Dynport Vaccine Company LLC's UEI?
Dynport Vaccine Company LLC's Unique Entity ID (UEI) in SAM.gov is LXNEGTYDR755.
What is Dynport Vaccine Company LLC's CAGE code?
Dynport Vaccine Company LLC's CAGE code is 1GFE1.
What is Dynport Vaccine Company LLC's primary NAICS code?
Dynport Vaccine Company LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Dynport Vaccine Company LLC located?
Dynport Vaccine Company LLC's physical address in SAM.gov is 12 W Church St #234, Frederick, MD 21701, USA.
Is Dynport Vaccine Company LLC registered in SAM.gov?
Yes. Dynport Vaccine Company LLC's SAM.gov registration is active through June 23, 2027.
Who is Dynport Vaccine Company LLC's parent company?
Dynport Vaccine Company LLC is part of General Dynamics Information Technology, Inc.
Which contract vehicles does Dynport Vaccine Company LLC hold?
Dynport Vaccine Company LLC holds a place on 4 federal contract vehicles, including EPCTU.
What is Dynport Vaccine Company LLC's most recent federal award?
Dynport Vaccine Company LLC's most recent federal contract award is Diagnostic pre-clinical services program -IDIQ - dynport (75N93023F00003), from National Institute of Allergy and Infectious Diseases, on June 20, 2023.
On GovTribe
See Dynport Vaccine Company LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors